Insulin resistance and hyperinsulinemia in patients with chronic liver disease and hepatocellular carcinoma

Clinical Medicine: Endocrinology and Diabetes

Volumn 2009, Issue 2, 2009, Pages 25-33

  Donado, Valter ^a   Balbi, Massimiliano ^a   Perciaccante, Antonio ^a   Casarin, Pietro ^a   Zanette, Giorgio ^a  

^a Pordenone Hospital   (Italy)

Author keywords

Chronic hepatitis C; Chronic liver disease; HOMA index; Insulin; Liver cirrhosis

Indexed keywords

ALPHA FETOPROTEIN; GLUCOSE; INSULIN;

ADULT; AGED; ALCOHOL ABUSE; ALCOHOL CONSUMPTION; ARTICLE; BODY MASS; CHRONIC LIVER DISEASE; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE ASSOCIATION; ENZYME IMMUNOASSAY; FEMALE; GENOTYPE; GLUCOSE BLOOD LEVEL; HEPATITIS C; HUMAN; HYPERINSULINEMIA; INSULIN BLOOD LEVEL; INSULIN RELEASE; INSULIN RESISTANCE; LIVER BIOPSY; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; MAJOR CLINICAL STUDY; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; PROTEIN BLOOD LEVEL; BLOOD SAMPLING; NON INSULIN DEPENDENT DIABETES MELLITUS;

EID: 70349514915     PISSN: None     EISSN: 11781173     Source Type: Journal    
DOI: None     Document Type: Article

References (33)

1. Schiel R, Beltschikow W, Steiner T, Stein G. Diabetes, insulin, and risk of cancer. Methods Find. Exp Clin Pharmacol. 2006;28:169-75.
2. Verlato G, Zoppini G, Bonora E, Muggeo M. Mortality from site-specific malignancies in type 2 diabetic patients from Verona. Diabetes Care. 2003;26:1047-51.
3. Caldwell SH, Crespo DM, Kang HS, Al-Osaimi AMS. Obesity and hepatocellular carcinoma. Gastroenterology. 2004;127:97-103.
4. El-Seragh HB, Tran T, Everhart JE. Diabetes increase the risk of chronic liver disease and hepatocellular carcinoma. Gastroenterology. 2004;126: 460-8.
5. Hickmann IJ, Macdonald GA. Impact of diabetes on the severity of liver disease. Am J Med. 2007;120:829-34.
6. García-Compean D, Jaquez-Quintana JO, Maldonado-Garza H. Hepatogenous diabetes. Current views of an ancient problem. Ann Hepatol. 2009;8:13-20.
7. Bugianesi E, Leone N, Vanni E, et al. Expanding the natural history of nonalcoholic steatohepatitis: from cryptogenic cirrhosis to hepatocellular carcinoma. Gastroenterology. 2002;123:134-40.
8. Moscatiello S, Manini R, Marchesini G. Diabetes and liver disease: an ominous association. Nutr Metab Cardiovasc Dis. 2007;17:63-70.
9. Garcia-Compean D, Jaquez-Quintana JO, Gonzalez-Gonzalez JA, Maldonado-Garza H. Liver cirrhosis and diabetes: risk factors, pathophysiology, clinical implications and management. World J Gastroenterol. 2009; 21:280-8.
10. Lecube A, Hernandez C, Genesca J, Simo R. Proinflammatory cytokines, insulin resistance, and insulin secretion in chronic hepatitis C patients. Diabetes Care. 2006;29:1096-101.
11. Guzman G, Brunt EM, Petrovic LM, Chejfec G, Layden TJ, Cotler SJ. Does non-alcoholic fatty liver disease predispose patients to hepatocellular carcinoma in the absence of cirrhosis? Arch Pathol Lab Med. 2008;132: 1761-6.
12. Petrides AS, Vogt C, Schulze-Berge D, Matthews D, Strohmeyer G. Pathogenesis of glucose intolerance and diabetes mellitus in cirrhosis. Hepatology. 1994;19:616-27.
13. Fartoux L, Poujol-Robert A, Guechot J, Wendum D, Poupon R, Serfaty L. Insulin resistance is a cause of steatosis and fibrosis progression in chronic hepatitis C. Hepatology. 2005;45:80-7.
14. Zein CO, Levy C, Bassu A, Zein NN. Chronic hepatitis C and type II diabetes mellitus: a prospective cross-sectional study. Am J Gastroenterol. 2005;100:48-55.
15. Lonardo A, Adinolfi LE, Petta S, Craxí A, Loria P. Hepatitis C and diabetes: the inevitable coincidence? Expert Rev Anti Infect Ther. 2009;7:293-303.
16. Machado MV, Cortez-Pinto H. Insulin resistance and steatosis in chronic hepatitis C. Ann Hepatol. 2009;8:S67-75.
17. Moucari R, Asselah T, Cazals-Hatem D, et al. Insulin resistance in Chronic Hepatitis C: association with genotypes 1 and 4, serum HCV RNA level, and liver fibrosis. Gastroenterology. 2008;134:416-23.
18. Tanaka N, Nagaya T, Komatsu M, et al. Insulin resistance and hepatitis C virus: a case-control study of non obese, non alcoholic and non steatotic hepatitis virus carriers with persistently normal serum aminotransferase. Liver Int. 2008;28:1104-11.
19. Donadon V, Balbi M, Casarin P, Vario A, Alberti A. Association between hepatocellular carcinoma and type 2 diabetes mellitus in Italy: potential role of insulin. World J Gastroenterol. 2008; 37:5695-700.
20. Llovet JM, Beaugrand M. Hepatocellular carcinoma: present status and future prospects. J Hepatol. 2003;38:S136-49.
21. American Diabetes Association. Report of the expert committee on the diagnosis and classification of diabetes mellitus. Diabetes Care. 2003; 26:S5-20.
22. Castera L, Forns X, Alberti A. Non-invasive evaluation of liver fibrosis using transient elastography. J Hepatol. 2008;48:835-47.
23. Corrao G, Lepore AR, Torchio P, et al. The effect of drinking coffee and smoking cigarettes on the risk of cirrhosis associated with alcohol consumption. A case-control study. Provincial Group for the Study of Chronic Liver Disease. Eur J Epidemiol. 1994;10:657-64.
24. Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentration in man. Diabetologia. 1985;28:412-9.
25. Wallace TM, Levy JC, Matthews DR. Use and Abuse of Homa modeling. Diabetes Care. 2004;27:1487-95.
26. Bonora E, Kiechl S, Willeit J, et al. Prevalence of insulin resistance in metabolic disorders. The Bruneck Study. Diabetes. 1998;47:1643-8.
27. Katz A, Nambi SS, Mather K, et al. Quantitative insulin sensitivity check index: a simple, accurate method for assessing insulin sensitivity in humans. J Clin Endocrinol Metab. 2000;85:2402-10.
28. Romero-Gomez M, Del Mar V, Andreade RJ, et al. Insulin resistance impairs sustained response rate to peginterferon plus ribavirin in chronic hepatitis C patients. Gastroenterology. 2005;128:636-41.
29. Lonardo A, Carulli N, Loria P. HCV and diabetes a two-question-based reappraisal. Dig Liver Dis. 2007;39:753-61.
30. D'Souza R, Sabin CA, Foster GR. Insulin resistance plays a significant role in liver fibrosis in chronic hepatitis C and in the response to antiviral therapy. Am J Gastroenterol. 2005;100:1509-15.
31. Bugianesi E, Marchesini G, Gentilcore E, et al. Fibrosis in genotype 3 chronic hepatitis C and nonalcoholic fatty liver disease: role of insulin resistance and hepatic steatosis. Hepatology. 2002;44:1648-55.
32. Cammà C, Petta S. Insulin resistance in HCV mono-infected and in HIV/HCV co-infected patients: Looking to the future. J Hepatol. 2009;50:648-51.
33. Rosenfeld RG. Insulin-like growth factors and the basis of growth. N Engl J Med. 2003;349:2184-6.